Serum Institute Of India - Pentavac (PFS/SD) - Diphtheria, Tetanus, Pertussis (Whole Cell), Hepatitis B (rDNA) and Haemophilus Type b Conjugate Vaccine (Adsorbed) I.P.

Pentavac PFS, Pentavac SD (liquid)

Diphtheria, Tetanus, Pertussis (Whole Cell), Hepatitis B (rDNA) and Haemophilus Type b Conjugate Vaccine (Adsorbed) I.P.

For the prevention of serious childhood diseases: Diphtheria, Tetanus, Pertussis (whooping cough), Hepatitis B and Haemophilus Influenzae type b.

Intramuscular Injection.

First dose is given at 6 weeks or 10 weeks or 14 weeks of age

Second dose is given anytime between 12-18 months of age

Each dose of 0.5 ml contains
Diphtheria Toxoid ≤ 25 Lf (≥ 30 IU)
Tetanus Toxoid ≥ 2.5 Lf (≥ 40 IU)
B. pertussis (whole cell) ≤ 16 OU (≥ 4.0 IU)*
HBsAg (rDNA) ≥ 10 mcg
Purified capsular Hib Polysaccharide (PRP)
Conjugated to Tetanus Toxoid (carrier protein) 10 mcg
⁺⁺⁺ Adsorbed on Aluminium Phosphate, Al ≤ 1.25 mg
Preservative: Thiomersal 0.005%
*The lower fiducial limit (P=0.95) of the estimated potency is not less than 2.0 IU. Adsorbed can be given at the age of 15-18 months.

Pentavac SD: 1 dose vial of 0.5 ml
Pentavac PFS: 1 x 0.5 ml - 1 dose pre-filled syringe